Gerald L. Andriole, MD

Gerald L. Andriole, MD

Barnes-Jewish Hospital and Washington University School of Medicine

St. Louis, Missouri

Gerald L. Andriole, Jr., MD, is the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center and Washington University School of Medicine in St. Louis, Missouri. Dr. Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He trained in surgery at Strong Memorial Hospital and the University of Rochester and completed urology residency at Brigham and Women’s Hospital and Harvard Medical School. Subsequently, he was a fellow in Urologic Oncology at the National Cancer Institute in Bethesda, Maryland. Dr. Andriole has over 25 years of consistent contributions in the areas of BPH and prostate cancer screening and prevention research. He has contributed well over 300 peer-reviewed publications and abstracts and serves on the editorial boards of several prestigious journals. He is Chairman of the Prostate Committee of the National Cancer Institute’s Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and is on the Steering Committee of the REDUCE Prostate Cancer Prevention Trial. He is a member of the American Urological Association, American Association for Cancer Research, the American Society of Clinical Oncology, American Surgical Association and the American Association of Genitourinary Surgeons among other societies.

Articles by Gerald L. Andriole, MD

Updates on the ERSPC and the PLCO Trials

Dr. Gerald L. Andriole, MD, reviews the designs, materials, and outcomes of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and The European Randomized Study of Screening for Prostate Cancer (ERSPC). He distinguishes between legitimate concerns and inappropriate criticisms of the trials. Also, he explains what this means for the practice of PSA testing.

Read More

Ask the Expert: Will More Individuals Over Time Be Diagnosed with Prostate Cancer?

Gerald L. Andriole, Jr., MD, Barnes-Jewish Hospital, St. Louis, Missouri, discusses whether over time more patients will be diagnosed with high-risk, local advanced, and metastatic prostate cancer. Interview produced by Prostatepedia Keywords: high-risk prostate cancer, local advanced prostate cancer, metastatic prostate cancer Presentations on Metastatic Prostate...

Read More

What Are Ways to Improve PSA?

Gerald L. Andriole, Jr., MD, Washington University, St. Louis, Missouri, discusses ways to improve PSA by looking at recent studies and the latest USPSTF recommendations.     To view slides from Dr. Andriole’s presentation at the 18th Annual Future Directions in Urology Symposium, click here. Keywords: prostate cancer, USPSTF, biopsy, metastatic, focal therapy...

Read More

The “Who’s” of Genomic Markers: Who to Treat

Dr. Gerald L. Andriole, Jr. presented “The “Who’s” of Genomic Markers: Who to Treat” at the 27th annual International Prostate Cancer Update meeting on Wednesday, January 25, 2017.       Keywords: prostate cancer, metastasis, genomic markers, prolaris, prostatectomy, biopsy How to cite: Andriole, Gerald L.  “The “Who’s” of Genomic Markers: Who to Treat.” January 25, 2017. Accessed Mar 2018. Transcript The “Who’s” of Genomic Markers: Who to Treat   Everybody has seen this, talked about it, conventional biopsy, completely misleading. We don’t have to beat that any further. And so if you really want to know if the guy in...

Read More
  • 1
  • 2

Join the GRU Community

- Why Join? -